Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Der Urologe. Ausg. A
|
July 8, 2021
[The PRECISE study: change or standstill in PCa diagnostics?]
R Al-Monajjed, L Schimmöller
Der Urologe. Ausg. A
|
May 26, 2018
[Effect of performing a single PSA screening : The CAP trial]
R Al-Monajjed, C Arsov, P Albers
Der Urologe. Ausg. A
|
April 1, 2021
[Risk-adapted prostate cancer screening-update 2021]
R Al-Monajjed, C Arsov, P Albers
Clinical Radiology
|
January 7, 2024
Benefit of dynamic contrast-enhanced (DCE) imaging for prostate cancer detection depending on readers experience in prostate MRI
F Ziayee, L Schimmöller, M Boschheidgen, et al.
Abdominal Radiology (New York)
|
May 16, 2022
Pre-operative magnetic resonance imaging can predict prostate cancer with risk for positive surgical margins
M Quentin, L Schimmöller, T Ullrich, et al.
Data in Brief
|
November 25, 2022
Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy
M Klingebiel, C Arsov, T Ullrich, et al.
Magnetic Resonance Imaging
|
February 12, 2025
Use of deep learning-accelerated T2 TSE for prostate MRI: Comparison with and without hyoscine butylbromide admission
M Boschheidgen, L Drewes, B Valentin, et al.
European Journal of Radiology
|
December 24, 2021
Comparison of 3 T mpMRI and pelvic CT examinations for detection of lymph node metastases in patients with prostate cancer
B Valentin, C Arsov, T Ullrich, et al.
Scientific Reports
|
April 26, 2022
Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate
M Boschheidgen, L Schimmöller, S Doerfler, et al.
European Journal of Radiology
|
February 16, 2021
Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsy
M Klingebiel, C Arsov, T Ullrich, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Der Urologe. Ausg. A
|
July 8, 2021
[The PRECISE study: change or standstill in PCa diagnostics?]
R Al-Monajjed, L Schimmöller
Der Urologe. Ausg. A
|
May 26, 2018
[Effect of performing a single PSA screening : The CAP trial]
R Al-Monajjed, C Arsov, P Albers
Der Urologe. Ausg. A
|
April 1, 2021
[Risk-adapted prostate cancer screening-update 2021]
R Al-Monajjed, C Arsov, P Albers
Clinical Radiology
|
January 7, 2024
Benefit of dynamic contrast-enhanced (DCE) imaging for prostate cancer detection depending on readers experience in prostate MRI
F Ziayee, L Schimmöller, M Boschheidgen, et al.
Abdominal Radiology (New York)
|
May 16, 2022
Pre-operative magnetic resonance imaging can predict prostate cancer with risk for positive surgical margins
M Quentin, L Schimmöller, T Ullrich, et al.
Data in Brief
|
November 25, 2022
Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy
M Klingebiel, C Arsov, T Ullrich, et al.
Magnetic Resonance Imaging
|
February 12, 2025
Use of deep learning-accelerated T2 TSE for prostate MRI: Comparison with and without hyoscine butylbromide admission
M Boschheidgen, L Drewes, B Valentin, et al.
European Journal of Radiology
|
December 24, 2021
Comparison of 3 T mpMRI and pelvic CT examinations for detection of lymph node metastases in patients with prostate cancer
B Valentin, C Arsov, T Ullrich, et al.
Scientific Reports
|
April 26, 2022
Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate
M Boschheidgen, L Schimmöller, S Doerfler, et al.
European Journal of Radiology
|
February 16, 2021
Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsy
M Klingebiel, C Arsov, T Ullrich, et al.
Page
of 2